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Proteins secreted by epidermal keratinocytes are
known to engage in functions other than those directly
associated with barrier formation. We have used a
previously published culture model to collect proteins
secreted by adult human epidermal keratinocytes.
Electrophoresis and microsequencing allowed us to
identify 20 proteins. The list of proteins includes
those known to be produced by keratinocytes (b-2
microglobulin, bIG-H3, calgranulin A, cathepsin B
and D, E-cadherin, gelatinase B, gelsolin, interstitial
collagenase, laminin B2t, plasminogen activator
inhibitor-1, protein 14–3-3e, SCC antigen, stratifin,
Keratinocytes are the main cellular constituent ofepidermis and generate a barrier by the formation ofa stratified squamous keratinizing epithelium. Inaddition, keratinocytes secrete a variety of proteinsthat have diverse roles in epidermal physiology. For
example, keratinocytes secrete collagen VII and laminin (Regauer
et al, 1990; Marinkovich et al, 1993), which are utilized to form a
basement membrane as well as proteinases and proteinase inhibitors
for matrix remodeling (Clark, 1993). Keratinocytes also release a
variety of cytokines, which have localized as well as systemic
inflammatory and immunologic reactions (Schro¨der, 1992). And
finally, keratinocytes secrete chemicals such as parathyroid hor-
mone-related peptide (Wu et al, 1991), endothelin (Yohn et al,
1993) and the C3 complement component (Basset-Seguin et al,
1990). These nonbarrier functions of keratinocytes are noted by
the production and release of various molecules to the extracellular
space. The discovery of these secreted proteins usually comes about
with some foreknowledge of their existence and/or function. For
example, interleukin-1 was initially isolated from macrophages and
observed to play a part in T cell activation. Because Langerhans
cells share certain properties with macrophages, cultures of murine
epidermal cells were tested and found to have interleukin-1 activity
(Sauder et al, 1982). Detailed examination revealed that the source
of interleukin-1 was not Langerhans cells but keratinocytes. The
list of keratinocyte-secreted proteins is therefore restricted to those
proteins for which some function or property is already known.
Celis and coworkers have compiled an extensive database of
proteins released by primary human epidermal keratinocytes in
suspension using two-dimensional electrophoresis and micro-
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and translationally controlled tumor protein) as well
as those not previously known to be secreted by
keratinocytes (epididymis secretory protein, maspin,
and anti-neoplastic urinary protein). In addition, two
proteins were identified that are not known to be
secreted (glutathione-S-transferase and heat shock pro-
tein 27/28 kDa). The varied nature of the proteins
identified suggests that epidermal keratinocytes have
physiologic functions that have yet to be identified. Key
words: collagenase/extracellular protease/metabolic labeling.
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sequencing (Rasmussen et al, 1992; Olsen et al, 1995). This method
of identifying secreted protein did not rely upon prior knowledge
of its presence or function. The viability of keratinocytes, however,
is known to drop rapidly when the cells are placed in suspension
(Rheinwald, 1979) and therefore, it is possible that some of the
proteins were released as a result of cell lysis. Furthermore, it is
not clear if changes in secretory activity were induced upon
disaggregation of the tissue and disruption of the epidermal archi-
tecture.
In 1994 Katz and Taichman described a two-chamber keratino-
cyte culture model in which the keratinocytes formed a fully
differentiated, stratified epithelium that was nourished from the
undersurface and exposed to air (Katz and Taichman, 1994). In
this model keratinocytes form a fully differentiated epithelium on
a porous membrane in the upper chamber with fibroblasts and a
serum-containing growth medium in the lower well. To analyze
protein secreted by keratinocytes, the upper chamber is placed in
a new well that lacks fibroblasts but contains a serum-free ‘‘collection
medium’’. In this culture model, keratinocytes secrete 10–20 µg of
protein per d per 106 cells of which only µ3% is derived from
lysed cells, as determined by the presence of minute amounts of
involucrin in the medium. A small amount of serum contamination
is present but this does not interfere with identification of proteins
that are metabolically labeled. Metabolic labeling with 35S-methion-
ine and two-dimensional gel electrophoresis discloses about 70
proteins, many of which are likely to represent post-translational
modifications. This method of collecting secreted proteins is also
not dependent upon prior knowledge of function or structure and
therefore provides an opportunity to survey secreted protein in an
unbiased way. In this report we have collected 35S-labeled protein
synthesized and secreted by adult epidermal keratinocytes and using
electrophoresis and microsequencing, managed to identify 20
proteins, some of which are quite unexpected.
Human, adult epidermal keratinocytes were maintained with the
aid of γ-irradiated 3T3 cells (Rheinwald and Green, 1975) in a
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Table I. Keratinocyte-secreted proteinsa
Protein FW Sequence identifiedd Amino acid Selected references
position in
protein
1 Gelsolin 85 697 ATASRGASQAG 28–38 f Kwiatkowski et al, 1988
Kubler and Watt, 1993
Olsen et al, 1995
2 Laminin B2t 130 871 DENPDIEXAD 435–444 f Sugiyama et al, 1995
3 Gelatinase B (MMP9) 78 384 APRQRQXXL 20–28 f Salo et al, 1994
Birkedal-Hansen et al, 1993
4 E-cadherin 97 456 DXVIPPIXXLENK 155–168 f Kemler, 1993
Bussemakers et al, 1993
5 βIG-H3 74 680 ASLPAEVLDSLVSNVe 149–163e LeBaron et al, 1995
6 Interstitial collagenase (MMP1) 54 007 FPATLETQEQDVDLV 20–34e SaarialhoKere et al, 1995
Petersen et al, 1990
7 Plasminogen activator inhibitor-1 45 060 VHHPXXYVAXLA 24–35 f Staiano-Coico et al, 1996
8 Cathepsin B 37 807 RXRPSFHPV 18–26 f Kawada et al, 1997
Keppler et al, 1996
9 Maspinb 42 138 TNPSTMANAKVe 259–269 f Zou et al, 1994
10 Cathepsin D 44 552 LVRIPLHKFTXXR 21–33 (5) Kawada et al, 1997
Kawada et al, 1996
11 SCC antigen (leupin) 44 534 AATYHVDRSG 70–79 Olsen et al, 1995
Suminami et al, 1991
Schneider et al, 1995
12 Protein 14–3-3ε 29 174 RX EQXEENXGGEDe 61–77 Aitken, 1995
13 Stratifin (14–3-3σ) 27 774 RVLSSIEQKSNEEGSEEKGPe 60–79 Leffers et al, 1993
Hermeking et al, 1997
14 Heat shock protein 22 327 RVSLDVNHFAPDELTe 96–110 Edwards et al, 1991
27/28 KDc Kindas-Mugge and Trautinger, 1994
15 Glutathione-S-transferasec 23 356 PPYTVVYFPVRGRXA 2–16 Shimizu et al, 1995
Blacker et al, 1991
Vessey et al, 1995
16 Translationally controlled 19 595 MIIYRDLISHDEMFS 1–15 Gross et al, 1989
tumor protein Bohm et al, 1991
Sanchez et al, 1997
17 β-2 microglobulin 13 714 IQRTPKIQVYSRHPA 21–35e Symington, 1989
Harrist et al, 1983
18 Calgranulin A 10 834 MLTELEKALNSIXDV 1–15 Saintigny et al, 1992
Madsen et al, 1992
19 Epididymis secretory proteinb 16 570 EPVQFKDXGXVD 20–31 f Kirchhoff et al, 1991
Kirchhoff et al, 1991
20 Anti-neoplastic urinary protein 1674 LKXYTXKEPMTSA 2–14 Ridge and Sloane, 1996
aProteins secreted by epidermal keratinocytes in culture were fractionated by two-dimensional gel electrophoresis and microsequencing was performed on a number of
distinct spots. Identification of the full length protein was made possible by comparison with known sequences in protein data banks.
bProtein not previously identified in keratinocytes.
cProtein not known to be secreted.
dAmino acids identified by microsequencing are denoted by a single letter according to standard IUB/IUPAC amino acid codes. An ‘X’ denotes an amino acid that could
not be identified by microsequencing.
eMicrosequencing was performed from an N-chlorosuccinimide fragment.
fThe position of the amino acids in the precursor protein is noted.
growth medium containing a 3:1 mix of Dulbecco’s modified Eagle
medium/F12, 5% fetal calf serum, adenine, insulin, epidermal
growth factor, cholera enterotoxin, HEPES, penicillin, and strepto-
mycin in amounts described elsewhere (Wu et al, 1982). At pass
three to seven keratinocytes (2 3 106 cells) were seeded into
24 mm Transwell Nucleopore polycarbonate tissue inserts (Costar,
Cambridge, MA) with 3 3 106 γ-irradiated 3T3 in the lower
chamber as described (Katz and Taichman, 1994). In some experi-
ments 100 mm tissue inserts were seeded with 2.5 3 107 ker-
atinocytes with 1.5 3 107 γ-irradiated 3T3 in the lower chamber.
On day 3, medium was removed from the upper chamber and
thereafter keratinocytes were nourished from the undersurface from
medium in the lower chamber. On days 10–15, secreted protein
was recovered in collection medium consisting of Dulbecco’s
modified Eagle medium/F12, hydrocortisone, adenine, insulin, and
HEPES. To remove residual serum protein, tissue inserts were put
through two cycles of two rinses with phosphate-buffered saline
(2 ml per rinse in the lower well) plus one incubation in collection
medium (1.3 ml for 1 h in the lower well). Secreted protein was
recovered in collection medium over a 16 h period and stored at –
80°C with phenylmethylsulfonyl fluoride (100 µg per ml). Repeated
collections of secreted protein from the same insert could be
performed by allowing an 8 h period in growth medium between
collections. In this way secreted protein could be harvested up to
five times from a single insert. Protein in the collection medium
was used only if the lactic acid dehydrogenase was less than 100 IU.
The amount of secreted protein in the medium ranged from 15 to
25 µg per ml. Metabolic labeling of secreted protein was achieved
with 24 mm inserts by adding 143°µCi S35-met (1175°µCi per
mmol, New England Nuclear, Boston, MA) to medium in the
lower chamber for a period of 6 h.
Nonlabeled secreted protein was precipitated with 2 volumes of
acetone at –20°C for 1 h and collected by centrifugation at 7700 3 g
for 40 min at 4°C. Proteins were resuspended and dialyzed
against water and then lyophilized (SpeedVac, Savant Instruments,
Farmingdale, NY). Metabolically labeled secreted protein was put
through three cycles of acetone precipitation and resuspended in
water, and used without dialysis or lyophilization. Electrophoresis
in the first dimension was by isoelectric focusing (Dunbar et al,
1990). For each gel, 800–1000 µg of nonlabeled protein and
1 3 106 cpm of S35-labeled protein were combined, dissolved in
urea buffer and electrophoresed for 19,400 Vh in a tube
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2.5 3 140 mm. The isoelectric focusing gel was suspended in
equilibration buffer and either frozen (–80°C) for use within 10 d
or run directly in the second dimension (Sambrook et al, 1989).
The sodium dodecyl sulfate/polyacrylamide gel electrophoresis gel
was transferred to Immobilon PSQ (Millipore, Bedford, MA) using
Tris-glycine buffer (39 mM glycine, 48 mM Tris base, 0.037%
sodium dodecyl sulfate, 20% methanol) overnight at 30 V. The
Immobilon was stained with 0.25% Coomassie Blue in a mixture
of methanol/water/acetic acid (45:45:10), destained, and exposed
to X-ray film. Spots which were both radioactive and Coomassie-
Blue-positive were cut out and sequenced by the Center for
Analysis and Synthesis of Macromolecules (SUNY at Stony Brook)
using a Perkin-Elmer (Applied Biosystem Division, Foster City,
CA) Model 475A protein sequencer and standard cycles. When
the protein to be sequenced was blocked at its N terminal, the
protein was treated with N-chlorosuccinimide (Lischwe and Ochs,
1982) and run on a 15% resolving gel. Internal fragments were
used for microsequencing. To obtain sufficient material, especially
for low molecular weight protein, 26 mg of secreted protein was
prefractionated on 10% sodium dodecyl sulfate polyacrylamide gel
electrophoresis tube gels (18 3 5 cm). The gels were cut into five
1 cm sections and similar sections combined and electroluted into
a dialysis bag. The eluted protein was then dialyzed against water
and concentrated by lyophilization. Prefractionated proteins from
one section were combined with S35-labeled protein, focused on
an isoelectric focusing gel and run in the second dimension on a
6%, 10%, or 15% gel, depending on the size range of the protein.
The amino acid sequence obtained was compared with sequences
in Brookhaven Protein Data Bank, GeneBank, GeneBank updates,
EMBL Data Library and EMBL Data Library updates using the
BLAST E-mail server at NIH (BLAST@ncbi.nlm.nih.gov).
For a protein to be analyzed, it must be present in amounts
sufficient to form a visible spot on a Coomassie-stained blot.
Generally, this corresponds to µ5 µg of protein. Protein secreted
in amounts below this will not be identified. For example, we
know that keratinocytes secrete apolipoprotein E at a rate of 0.97 ng
per h per 106 cells (Gordon et al, 1989). Apolipoprotein E was not
identified in our analysis. In spite of our efforts to remove serum
albumin from the cultures, some was always present in the medium
and this interfered with analysis in that region of the gel. It should
also be noted that only five of the 19 proteins identified were
blocked at the amino terminus and sequencing was performed on
an internal N-chlorosuccinimide fragment. As the amino terminus
of a secreted protein encodes secretory properties and is usually
removed during membrane translocation, the low number of
blocked proteins is not unexpected.
Proteins identified in this way are listed in Table I and their
position on two-dimensional gel electrophoresis is shown in Fig 1.
Many of the proteins have been identified previously by Celis and
coworkers (Rasmussen et al, 1992; Olsen et al, 1995). Most of the
proteins identified are known or thought to be involved in matrix
remodeling, either as a proteinase or as a proteinase inhibitor
(cathepsin B and D, epididymis secretory protein, gelatinase B,
interstitial collagenase, maspin, plasminogen activator inhibitor-1,
and SCC antigen). One protein (laminin B2t) is a structural
component of the basement membrane and another (β-2 micro-
globulin) is a component of the major histocompatibility complex
antigen. One protein (βIG-H3) promotes adhesion and spreading
of fibroblasts, another (calgranulin) has similarity to fatty acid
binding proteins and one (gelsolin) has actin binding properties.
Anti-neoplastic urinary protein is a poorly characterized protein that
has not been previously identified in keratinocytes and translationally
controlled tumor protein has no known function. Two proteins
(protein 14–3-3ε and stratifin) are not known to be secreted but
have been recovered in the keratinocyte culture medium (Celis
et al, 1994). The significance of this is unclear. Two proteins
(glutathione-S-transferase and heat shock protein 27/28 KD) are
not known to be secreted and the explanation for their presence
in the medium is unclear. It is unlikely that these two proteins are
contaminants from cell lysis because lactic acid dehydrogenase levels
Figure 1. Identification of keratinocyte-secreted protein. Secreted
protein metabolically labeled with 35S-met was analyzed by two-
dimensional gel electrophoresis. The two-dimensional gel electrophoretic
pattern shown here has been described previously (Katz and Taichman,
1994). Peptide mapping indicates that the proteins labeled as nos 8 and 10
are post-translational modifications. The protein spot actually sequenced is
identified by the straight line. Further information on each protein is
provided in Table I.
were ,100 IU in all batches of medium used for protein isolation.
In addition, we know from reconstruction experiments that µ3%
of the metabolically labeled protein recovered in the medium of
these lifted cultures can be accounted for by cell lysis (Katz and
Taichman, 1994). It is possible that the amino acid sequence
identified by microsequencing is shared by or is similar to sequences
present in other secreted proteins. Secreted proteins are likely to
have functions that involve other cells, either in close proximity
or at some distance. The secreted proteins identified in this study
may stimulate further research into other, as yet to be identified,
functions of epidermis.
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